Home
Conditions
Tumor Virus Infections

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies

Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Not Yet Recruiting

mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults

NCT07557602

Conditions: DNA Virus Infections, EBV, Epstein-Barr Virus Infections, +4 more
Locations: Q-Pharm Pty Ltd/Nucleus Network Pty Ltd Herston, Queensland, Australia

Nucleus Network Pty Ltd Melbourne, Victoria, Australia

View Trial Details

Not Yet Recruiting

New Treatment of Common Wart

NCT07543926

Conditions: Common Warts (Verruca Vulgaris), DNA Virus Infections, Infections, +8 more
Locations: Sohag University Sohag, Egypt

View Trial Details

Not Yet Recruiting

Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors

NCT07539610

Conditions: B Acute Lymphoblastic Leukemia/Lymphoma, B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +16 more
Locations: Institute of Hematology, Chinese Academy of Medical Sciences & Hospital of Hematology, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

NCT07476729

Conditions: B-Cell Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: St. Anna Kinderspital GmbH Vienna, Austria

Ghent University Hospital Ghent, Belgium

Fakultni Nemocnice V Motole Prague, Czechia

Rigshospitalet Copenhagen, Denmark

View all 20 locations

View Trial Details

Not Yet Recruiting

A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)

NCT07418034

Conditions: Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +38 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R

NCT07412405

Conditions: Adult B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +31 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV

NCT07303751

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +29 more
Locations: Kambia Research Centre Freetown, Sierra Leone

View Trial Details

Not Yet Recruiting

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

NCT07396714

Conditions: DNA Virus Infections, Infections, Papillomavirus Infections, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in EBV Negative Kidney Transplant Recipients Receiving an Organ From EBV Positive Donors

NCT07368153

Conditions: DNA Virus Infections, EBV Infections, Epstein-Barr Virus Infections, +5 more
Locations: University Hospital Basel Basel, Switzerland

View Trial Details

Not Yet Recruiting

Evaluation of the Effect of a Dietary Supplement Based on EGCG, Vitamin B12, Hyaluronic Acid, and Folic Acid on the Maintenance of Physiological Balance and the Natural Defenses of the Male Genital System in Subjects Exposed to HPV Infection.

NCT07344337

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +13 more
Locations: Not specified

View Trial Details

Tumor Virus Infections

Tumor Virus Infections trial results

Related conditions